# Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants

> **NCT07168148** · PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 3 (actual)

## Conditions studied

- Nasal Obstruction
- Chronic Rhinitis

## Interventions

- **DRUG:** Oxymetazoline + Triamcinolone

## Key facts

- **NCT ID:** NCT07168148
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-11-10
- **Primary completion:** 2026-03-19
- **Final completion:** 2026-03-19
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** low recruitment
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07168148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07168148, "Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07168148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*